Nature Communications (May 2022)

SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity

  • Wuji Zhang,
  • Brendon Y. Chua,
  • Kevin J. Selva,
  • Lukasz Kedzierski,
  • Thomas M. Ashhurst,
  • Ebene R. Haycroft,
  • Suzanne K. Shoffner-Beck,
  • Luca Hensen,
  • David F. Boyd,
  • Fiona James,
  • Effie Mouhtouris,
  • Jason C. Kwong,
  • Kyra Y. L. Chua,
  • George Drewett,
  • Ana Copaescu,
  • Julie E. Dobson,
  • Louise C. Rowntree,
  • Jennifer R. Habel,
  • Lilith F. Allen,
  • Hui-Fern Koay,
  • Jessica A. Neil,
  • Matthew J. Gartner,
  • Christina Y. Lee,
  • Patiyan Andersson,
  • Sadid F. Khan,
  • Luke Blakeway,
  • Jessica Wisniewski,
  • James H. McMahon,
  • Erica E. Vine,
  • Anthony L. Cunningham,
  • Jennifer Audsley,
  • Irani Thevarajan,
  • Torsten Seemann,
  • Norelle L. Sherry,
  • Fatima Amanat,
  • Florian Krammer,
  • Sarah L. Londrigan,
  • Linda M. Wakim,
  • Nicholas J. C. King,
  • Dale I. Godfrey,
  • Laura K. Mackay,
  • Paul G. Thomas,
  • Suellen Nicholson,
  • Kelly B. Arnold,
  • Amy W. Chung,
  • Natasha E. Holmes,
  • Olivia C. Smibert,
  • Jason A. Trubiano,
  • Claire L. Gordon,
  • Thi H. O. Nguyen,
  • Katherine Kedzierska

DOI
https://doi.org/10.1038/s41467-022-30088-y
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 18

Abstract

Read online

The immune response to SARS-CoV-2 infection is variable but has been linked to prognosis and the development of severe immunopathology. Here the authors assess a range of immune parameters in both peripheral blood and respiratory samples, providing a comparative assessment of the immune response between these compartments and their potential impact on immune-pathogenesis.